GlassScriptPhysician profile
Imran T Ismail
NPI 1962650028
$9,400.16
in general payments reported to CMS, 2019-2025
45 companies · $761 in 2025
The $761 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,700 · 2020: $1,420 · 2021: $1,473 · 2022: $1,148 · 2023: $954 · 2024: $944 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,659.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $1,492.53 | 2019-2021 | |
| Cardiovascular Systems INC. | $933.80 | 2019-2023 | |
| Abbott Laboratories | $572.01 | 2019-2024 | Aveir, Perclose Prostyle |
| Boston Scientific Corporation | $558.25 | 2019-2025 | Farapulse, Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack |
| Janssen Pharmaceuticals, INC | $526.20 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $522.67 | 2019-2024 | |
| Amgen INC. | $519.31 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $506.67 | 2019-2024 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $504.41 | 2019-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $464.65 | 2019-2024 | Farxiga |
| Pfizer INC. | $363.84 | 2019-2025 | |
| Medtronic, INC. | $225.75 | 2021-2025 | Linq II |
| Angiodynamics, INC. | $186.26 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $178.28 | 2023-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $159.04 | 2019-2024 | Camzyos |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $148.52 | 2025 | |
| Endologix LLC | $140.45 | 2022 | |
| Chiesi USA, INC. | $132.84 | 2019-2022 | |
| Astellas Pharma US INC | $110.86 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $93.69 | 2023-2024 | Inpefa |
| Edwards Lifesciences Corporation | $88.75 | 2024-2025 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $87.98 | 2024-2025 | Onpattro |
| Irhythm Technologies, INC. | $80.17 | 2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $73.37 | 2021 | |
| Inari Medical, INC. | $72.65 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $68.12 | 2022-2023 | Uptravi |
| Amarin Pharma, INC. | $62.03 | 2021 | |
| Medtronic Vascular, INC. | $60.98 | 2019-2020 | |
| Atricure, INC. | $47.33 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Sanofi-Aventis U.S. LLC | $43.36 | 2023-2024 | |
| Merck Sharp & Dohme LLC | $39.03 | 2021 | |
| Mallinckrodt Hospital Products INC. | $38.15 | 2025 | Terlivaz |
| Kestra Medical Technology Services, INC. | $35.46 | 2024 | Assure Wcd |
| Philips North America LLC | $32.92 | 2020 | |
| Stryker Corporation | $31.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Imperative Care, INC | $28.98 | 2024 | Symphony Catheter |
| Kowa Pharmaceuticals America, INC. | $25.46 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.66 | 2021 | |
| Novo Nordisk INC | $22.26 | 2024 | Ozempic |
| Shockwave Medical, INC | $20.28 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kiniksa Pharmaceuticals International, Plc | $17.68 | 2024 | Arcalyst |
| Preventice Services, LLC | $16.34 | 2020 | |
| Medicomp INC | $15.21 | 2019 | |
| Livanova USA, INC. | $14.44 | 2021 | |
| United Therapeutics Corporation | $13.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imran Ismail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.